Log In
BCIQ
Print this Print this
 

ANAVEX 1-41

  Manage Alerts
Collapse Summary General Information
Company Anavex Life Sciences Corp.
DescriptionTetrahydrofuranic compound that modulates muscarinic and sigma-1 receptor
Molecular Target Sigma-1 receptor ; Muscarinic receptor
Mechanism of ActionSigma-1 receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today